Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
American Society for Microbiology
Online
2023-10-26
DOI
10.1128/aac.00810-23
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medication Management in the Critically Ill Patient with Acute Kidney Injury
- (2023) Michael L. Behal et al. Clinical Journal of the American Society of Nephrology
- Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter
- (2023) Uwe Liebchen et al. INTENSIVE CARE MEDICINE
- Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy
- (2023) Erin F. Barreto et al. PHARMACOTHERAPY
- Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials
- (2023) Maria Sanz-Codina et al. CLINICAL MICROBIOLOGY AND INFECTION
- Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
- (2022) Justine Heitzmann et al. Pharmaceutics
- Clinical Pharmacokinetics and Pharmacodynamics of Cefepime
- (2022) Gwendolyn M. Pais et al. CLINICAL PHARMACOKINETICS
- Estimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs . serum creatinine
- (2022) Hyun Gi Yun et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
- (2022) Tim M. J. Ewoldt et al. INTENSIVE CARE MEDICINE
- From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics
- (2021) Sebastian G. Wicha et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
- (2021) Cynthia Delgado et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum
- (2021) Matthew W Bjergum et al. Journal of Applied Laboratory Medicine
- Implementation and evaluation of sepsis surveillance and decision support in medical ICU and emergency department
- (2021) Kirill Lipatov et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement Therapy
- (2021) Mohammad H. Al-Shaer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics
- (2021) Mohammad H. Alshaer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1109. Pharmacokinetics and Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
- (2021) Abigail K Kois et al. Open Forum Infectious Diseases
- Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime
- (2020) Jiajun Liu et al. CLINICAL PHARMACOKINETICS
- Population pharmacokinetics and target attainment of cefepime in critically ill patients and guidance for initial dosing
- (2020) Mohammad H. Al-Shaer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Patterns of Cystatin C Uptake and Use Across and Within Hospitals
- (2020) Hilary R. Teaford et al. MAYO CLINIC PROCEEDINGS
- Modeling Kinetic Glomerular Filtration Rate in Adults with Stable and Unstable Kidney Function: Vancomycin as the Motivating Example
- (2020) Manjunath P. Pai et al. PHARMACOTHERAPY
- Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
- (2020) Adam S. Darwich et al. Annual Review of Pharmacology and Toxicology
- One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?
- (2020) Frédéric Sangla et al. PLoS One
- Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia
- (2019) Lisa M. Daniels et al. SUPPORTIVE CARE IN CANCER
- Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review
- (2019) Erin F. Barreto et al. MAYO CLINIC PROCEEDINGS
- Target-Controlled Infusion of Cefepime in Critically Ill Patients
- (2019) Stijn Jonckheere et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimising drug dosing in patients receiving extracorporeal membrane oxygenation
- (2018) Vesa Cheng et al. Journal of Thoracic Disease
- Impact of Serum Cystatin C-Based Glomerular Filtration Rate Estimates on Drug Dose Selection in Hospitalized Patients
- (2018) Bradley J. Peters et al. PHARMACOTHERAPY
- Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial
- (2017) Andrew A. Udy et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
- (2017) Lakhmir S. Chawla et al. Nature Reviews Nephrology
- A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU
- (2016) Stijn Jonckheere et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement
- (2015) Salmaan Kanji et al. CLINICAL PHARMACOKINETICS
- Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study
- (2015) Angela Huttner et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Drug absorption, distribution, metabolism and excretion considerations in critically ill adults
- (2013) Derek J Roberts et al. Expert Opinion on Drug Metabolism & Toxicology
- Retooling the Creatinine Clearance Equation to Estimate Kinetic GFR when the Plasma Creatinine Is Changing Acutely
- (2013) S. Chen JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation
- (2012) Kiran Shekar et al. JOURNAL OF CRITICAL CARE
- Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
- (2011) Andrew A. Udy et al. CHEST
- Cefepime in intensive care unit patients: Validation of a population pharmacokinetic approach and influence of covariables
- (2011) B. Georges et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Septic shock: A multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality*
- (2010) Garrett E. Schramm et al. CRITICAL CARE MEDICINE
- Informatics Infrastructure for Syndrome Surveillance, Decision Support, Reporting, and Modeling of Critical Illness
- (2010) Vitaly Herasevich et al. MAYO CLINIC PROCEEDINGS
- Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia
- (2009) A. M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
- (2007) B.J. Anderson et al. Annual Review of Pharmacology and Toxicology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started